Skip to main content
# Title Type of news Date Link of news
262 Safety Signal of Azathioprine and the Risk of Optic neuritis Signal
261 Safety Signal of Tozinameran and the Risk of Acute respiratory distress syndrome Signal
260 Safety Signal of Glucose and the Risk of Hyperkalemia Signal
259 Safety Signal of Carbamazepine and the Risk of Encephalopathy Signal
258 Safety Signals Identified by the SFDA (April - June) 2026 Signal
257 Safety Signal of Cefadroxil and the Risk of Dyspnea (Shortness Of Breath) Signal
256 Safety Signal of Aripiprazole and the Risk of Memory impairment Signal
255 Signal of Apremilast and the Risk of Diverticulitis Signal
254 Safety Signal of Apixaban and the Risk of Hyperacidity Signal
253 Safety Signal of Amiodarone and the Risk of Acute kidney injury Signal
Displaying 1 - 10 of 264